STOCK TITAN

Xylo Technologies SEC Filings

XYLO NASDAQ

Welcome to our dedicated page for Xylo Technologies SEC filings (Ticker: XYLO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking disclosures for a company that juggles incision-less surgical tools, e-commerce traffic engines, and electric-vehicle safety systems isn’t easy. XYLO’s SEC documents often exceed 250 pages, mixing FDA milestones for its MUSE GERD device with revenue from online advertising affiliates. If you have ever asked, “How do I read XYLO’s annual report 10-K?” or “Where can I monitor XYLO insider trading Form 4 transactions in real time?”, this page was built for you.

Stock Titan’s AI-powered analysis converts dense filings into plain-language briefs. Open a 10-Q and our engine tags the segment that shows whether medical-device sales outpaced the digital-commerce unit. Get instant alerts on “XYLO quarterly earnings report 10-Q filing” and see key metrics side-by-side with prior quarters. Form 4 insider data are streamed the moment executives trade—search “XYLO Form 4 insider transactions real-time” and you’ll land here first.

Every filing type is covered and explained simply: the annual report—searchable as “XYLO annual report 10-K simplified”—breaks out R&D spend on ultrasonic stapling; 8-K material events explained detail joint ventures on drone safety; the proxy statement reveals executive compensation structures for those comparing “XYLO proxy statement executive compensation”. Our platform answers real investor questions: How are equity stakes in EV robotics recorded? Which directors bought shares last week? What risk factors are new? Instead of wading through PDFs, use our AI summaries, comparative tables, and keyword search to grasp the story faster and make confident decisions.

Rhea-AI Summary

L.I.A. Pure Capital Ltd. and CEO Kfir Silberman have filed Amendment No. 5 to their Schedule 13D regarding Xylo Technologies. The filing discloses significant developments in their ownership position and a major corporate transaction:

Key details:

  • The reporting persons currently own 2,980,000 ordinary shares (74,500 ADSs), representing 5.81% of outstanding shares
  • On June 22, 2025, the Tel Aviv district court approved an arrangement for Pure Capital to acquire all remaining shares of Xylo Technologies
  • The arrangement must be completed within 180 days of court approval
  • Upon completion, Xylo will become a wholly-owned subsidiary of Pure Capital
  • The company will subsequently delist from Nasdaq and terminate its public company obligations

Recent transactions include purchases of 1,000 ADSs at $5.004 on June 18 and 1,000 ADSs at $4.986 on June 20, 2025. Total investment in shares amounts to approximately $314,500.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Xylo Technologies Ltd. ("XYLO") reported that the Tel Aviv District Court (Economic Division) approved the previously disclosed Section 350 Arrangement on 22 June 2025. The Arrangement, already endorsed by shareholders on 27 May 2025, must be completed within 180 days (by mid-December 2025).

Under the Arrangement, L.I.A. Pure Capital Ltd. will acquire all XYLO shares it does not currently hold, turning XYLO into its wholly-owned subsidiary. Upon closing, XYLO’s American Depositary Shares will be delisted from Nasdaq and the company will cease to have U.S. public-company reporting obligations. Management will provide further scheduling and procedural updates as they become available.

The filing includes customary forward-looking-statement disclaimers and notes that this Form 6-K is incorporated by reference into several outstanding shelf and equity incentive registration statements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Xylo Technologies (XYLO)?

The current stock price of Xylo Technologies (XYLO) is $5.0018 as of June 28, 2025.

What is the market cap of Xylo Technologies (XYLO)?

The market cap of Xylo Technologies (XYLO) is approximately 6.5M.

What is the core business of Xylo Technologies Ltd?

Xylo Technologies is focused on developing innovative medical devices, including direct vision systems for minimally invasive procedures, as well as safety systems for drones and the electric vehicle sector.

In which industries does Xylo Technologies operate?

The company operates in advanced medical solutions, digital commerce, and the electric vehicle market, integrating technology across healthcare, online platforms, and mobility sectors.

What is the significance of the MUSE system?

The MUSE system is a single-use, incision-less device designed for the treatment of gastroesophageal reflux disease, showcasing Xylo's capability in advancing minimally invasive surgical technologies.

How does Xylo Technologies generate value?

Xylo leverages proprietary technology and strategic partnerships to innovate across multiple sectors, offering diversified revenue streams from its medical device products and digital commerce solutions.

What strategic partnerships does Xylo engage in?

Xylo maintains affiliations with companies in robotics, artificial intelligence, digital advertising, and event management, thereby building an ecosystem that enhances its technological capabilities and market reach.

How has the company diversified its operations?

Beyond medical devices, Xylo has expanded its portfolio to include digital commerce platforms and EV safety solutions, ensuring a balanced approach to technological innovation across different market segments.

What geographical markets does Xylo Technologies serve?

The company has established a presence in key regions including the United States, Europe, Great Britain, Israel, Canada, and Asia, reflecting its commitment to a global operational footprint.

How does Xylo maintain its industry expertise?

Through continuous investment in research and development, strategic growth partnerships, and a diversified portfolio, Xylo consistently demonstrates high-level expertise in medical technology, digital platforms, and safety systems.
Xylo Technologies

NASDAQ:XYLO

XYLO Rankings

XYLO Stock Data

6.53M
1.21M
9.9%
7.95%
0.72%
Medical Devices
Healthcare
Link
Israel
Tel Aviv